CRT-502 Everolimus-Eluting Stent Equalizes the Clinical Outcome Among Patients Presenting with Paclitaxel and Limus Stent Failure

Hideaki Ota; Marco A. Magalhaes; Al Fazir Omar; Joshua P. Loh; Lakshmana K. Pendyala; Sa`ar Minha; Nevin Baker; Ricardo Orlando Escarcega; Wenjie Tian; Rebecca Torguson; Fang Chen; Lowell F. Satler; William O. Suddath; Augusto Pichard; Ron Waksman

doi:10.1016/j.jcin.2013.12.144

CRT-502 Everolimus-Eluting Stent Equalizes the Clinical Outcome Among Patients Presenting with Paclitaxel and Limus Stent Failure

By Hideaki Ota, Marco A. Magalhaes, Al Fazir Omar, Joshua P. Loh, Lakshmana K. Pendyala, Sa`ar Minha, Nevin Baker, Ricardo Orlando Escarcega, Wenjie Tian, Rebecca Torguson, Fang Chen, Lowell F. Satler, William O. Suddath, Augusto Pichard and Ron Waksman

Publisher: 'Elsevier BV'

Year: 2014

DOI identifier: 10.1016/j.jcin.2013.12.144

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://doi.org/10.1016/j.jcin... (external link)

CRT-502 Everolimus-Eluting Stent Equalizes the Clinical Outcome Among Patients Presenting with Paclitaxel and Limus Stent Failure

Suggested articles